BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3495087)

  • 1. DDAVP and life-threatening diffuse gastric bleeding in uraemia. Case report.
    Juhl A; Jørgensen F
    Acta Chir Scand; 1987 Jan; 153(1):75-7. PubMed ID: 3495087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Desmopressin in the treatment of hemorrhagic diathesis].
    Haar D; Hasselbalch HC
    Ugeskr Laeger; 1995 Nov; 157(48):6713-5. PubMed ID: 8540136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Deamino-8-d-arginine vasopressin (DDAVP): a potential new treatment for the bleeding diathesis of acute renal failure.
    Watson AJ; Keogh JA
    Pharmatherapeutica; 1984; 3(9):618-22. PubMed ID: 6728864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal deamino-8-D-arginine vasopressin shortens the bleeding time in uremia.
    Shapiro MD; Kelleher SP
    Am J Nephrol; 1984; 4(4):260-1. PubMed ID: 6332534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of uremic bleeding.
    Couch P; Stumpf JL
    Clin Pharm; 1990 Sep; 9(9):673-81. PubMed ID: 2171866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Force monitoring of clot retraction during DDAVP therapy for the qualitative platelet disorder of uraemia: report of a case.
    Carr ME; Zekert SL
    Blood Coagul Fibrinolysis; 1991 Apr; 2(2):303-8. PubMed ID: 1893061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shortening of bleeding time by 1-deamino-8-arginine vasopressin (DDAVP) in the absence of platelet von Willebrand factor in Gray platelet syndrome.
    Pfueller SL; Howard MA; White JG; Menon C; Berry EW
    Thromb Haemost; 1987 Dec; 58(4):1060-3. PubMed ID: 3502198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of 1-deamino-8-D-arginine vasopressin (DDAVP) on bleeding time in uremic patients].
    Alarcón F; Mezzano D; Vial S; Pereira J
    Rev Med Chil; 1985 Aug; 113(8):763-8. PubMed ID: 3938558
    [No Abstract]   [Full Text] [Related]  

  • 9. Bleeding disorders in uremia: pathophysiology and treatment.
    Remuzzi G
    Adv Nephrol Necker Hosp; 1989; 18():171-86. PubMed ID: 2493714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of von Willebrand's disease--successful application of 1-deamino-8-D-arginine vasopressin (DDAVP) to ovarian bleeding].
    Shiraishi K; Ebata H; Sato K; Tanaka M; Nouno R; Mashiko N; Yamaguchi G; Kubo Y; Tanikawa K; Ide K
    Rinsho Ketsueki; 1983 Dec; 24(12):1674-9. PubMed ID: 6608600
    [No Abstract]   [Full Text] [Related]  

  • 11. Conjugated estrogens for the management of gastrointestinal bleeding secondary to uremia of acute renal failure.
    Heunisch C; Resnick DJ; Vitello JM; Martin SJ
    Pharmacotherapy; 1998; 18(1):210-7. PubMed ID: 9469696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-Deamino-8-D-arginine-vasopressin--an alternative in the management of mild haemophilia A and von Willebrand's disease.
    Niessner H; Korninger C
    Wien Klin Wochenschr; 1983 Nov; 95(21):753-7. PubMed ID: 6424339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Deamino-8-D-arginine vasopressin as a therapy for the bleeding diathesis of renal failure.
    Watson AJ; Keogh JA
    Am J Nephrol; 1984; 4(1):49-51. PubMed ID: 6731500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose intranasal desmopressin (DDAVP) for uremic bleeding.
    Ozen S; Saatci U; Bakkaloglu A; Ozdemir S; Ozdemir O; Besbas N
    Nephron; 1997; 75(1):119-20. PubMed ID: 9031290
    [No Abstract]   [Full Text] [Related]  

  • 15. Desmopressin: a new drug for the treatment of bleeding disorders.
    Haas D; Nace GS
    J Nephrol Nurs; 1985; 2(2):72-3. PubMed ID: 3845983
    [No Abstract]   [Full Text] [Related]  

  • 16. Subcutaneous desmopressin (DDAVP) shortens the bleeding time in uremia.
    Viganò GL; Mannucci PM; Lattuada A; Harris A; Remuzzi G
    Am J Hematol; 1989 May; 31(1):32-5. PubMed ID: 2705441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild bleeding disorders: review of 120 patients.
    Bolton-Maggs P; Wilkinson LS
    Clin Lab Haematol; 1984; 6(3):247-56. PubMed ID: 6335071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmopressin in inherited disorders of platelet function.
    Coppola A; Di Minno G
    Haemophilia; 2008 Jan; 14 Suppl 1():31-9. PubMed ID: 18173692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of bleeding in severely uremic patients undergoing oral surgery.
    Buckley DJ; Barrett AP; Koutts J; Stewart JH
    Oral Surg Oral Med Oral Pathol; 1986 Jun; 61(6):546-9. PubMed ID: 2941716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.